Urological medicine is undergoing significant transformation as a result of rapid scientific advances spanning precision medicine, molecular biology, and innovative therapeutics. Urological diseases, particularly urological cancers such as those affecting the bladder, prostate, and kidneys, present persistent and growing challenges due to their clinical heterogeneity, rising incidence, and complexity in response to traditional therapies. While improved surgical techniques and systemic therapies have led to incremental gains, current standard treatments often struggle with the obstacles of interpatient variability, tumor diversity, and resistance to established interventions. This has underscored the urgent need for a more precise and individualized approach, grounded in molecular and clinical insights, to overcome the shortcomings of conventional strategies.

Recent years have witnessed an explosion in multi-omics technologies, encompassing genomics, transcriptomics, proteomics, and metabolomics, which have revolutionized our understanding of disease pathogenesis and unveiled promising new targets for intervention. At the same time, developments in targeted therapies, immunotherapy, gene and cell-based treatments, biomaterials-enabled drug delivery, and the application of artificial intelligence to diagnostic and therapeutic algorithms are changing how urological diseases are managed. Translational research that bridges basic discoveries with clinical practice is increasingly recognized as crucial for converting scientific innovation into tangible benefits for patients. Nevertheless, questions remain regarding optimal integration of these technologies, mechanisms underlying treatment failure, and strategies to ensure accessible, personalized care for diverse patient populations.

This Research Topic aims to showcase recent progress and future directions in the realm of precision medicine and innovative therapies for urological diseases. By assembling contributions from basic, translational, and clinical research, the objective is to deepen understanding of disease mechanisms, promote identification of actionable molecular targets, and evaluate novel diagnostic and therapeutic strategies. This platform invites interdisciplinary collaboration between clinicians, researchers, and engineers, emphasizing how mechanistically informed approaches can not only improve efficacy but also overcome treatment resistance and deliver more tailored care. Ultimately, the goal is to accelerate the translation of cutting-edge advancements from the laboratory to the clinic and foster the development of new paradigms in personalized urological disease management.

This Research Topic encompasses both malignant and non-malignant urological disorders, with a focus on precision-based diagnostic, predictive, and therapeutic innovation. Submissions are expected to emphasize originality, mechanistic discovery, translational application, and the potential to advance person-centered urological care. We welcome articles addressing, but not limited to, the following themes:
• Precision diagnostics, biomarkers, and risk stratification in urology
• Targeted and immune-based therapeutic interventions
• Tumor microenvironment–oriented strategies
• Translational studies connecting basic research to clinical implementation
• Emerging technologies, including biomaterials and nanomedicine
• Artificial intelligence in diagnostic, prognostic, or therapeutic contexts
• Overcoming therapeutic resistance and improving patient stratification
• Development and validation of new drug delivery and monitoring platforms

Confirm your expert contribution

Precision Medicine and Novel Therapeutic Approaches in Urological Diseases